Roche Holdings

San Diego-Based Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc. for $1.5B

Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR)...